SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer ...

Despite this significant citation milestone, Dr. Touloukian remains focused on what liesahead. He is currently involved in several projects exploring the next generation of immunotherapeutic ...

When I asked John Savage, the retired co-founder of the Department of Computer Science at Brown University, what the ...

New research reveals that L-aspartic acid, a common amino acid found in blood plasma, may play a critical role in predicting ...

Researchers in China say the bacteria in your gut—and beyond—may play a role in your chance of developing one of the leading ...

CRISPR technology is transforming modern medicine by enabling precise DNA editing to treat genetic disorders, including sickle cell anemia and beta-thalassemia, experts say.

A study led by Karolinska Institutet in Sweden has demonstrated that the use of an AI tool can improve the pathologists' ...

Over the last several months, a deep sense of unease has settled over laboratories across the United States. Researchers at every stage — from graduate students to senior faculty — ...

The Global Multi-omics Market comprising primarily Genomics, Transcriptomics, Proteomics, & Metabonomics is set to witness a ...

Australians aged in their 30s and 40s are experiencing unprecedented and in some cases world-leading rates of at least 10 ...

Sustainable change requires improved study design, market incentives, and patient involvement, write Kate Womersley and colleagues For too long, medical research has defaulted to male physiology, ...